Custom Biomarker Assay Development for Regulatory and Translational Studies
Accelevir designs and validates fit-for-purpose biomarker assays that meet the specific needs of your therapeutic program. Our expertise spans predictive, pharmacodynamic, and safety biomarkers for cell therapy, gene therapy, and vaccine platforms.
Technical Capabilities:
- Biomarker discovery via multiplex cytokine/chemokine profiling.
- Flow cytometry-based immune subset and activation marker panels.
- qPCR/dPCR assays for nucleic acid biomarkers.
- Custom assay validation under CLIA/GLP conditions.
Why Partner with Accelevir:
- Deep domain knowledge in immunovirology biomarker development.
- Ability to scale from discovery to regulated trial testing.